Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

The Israel Defense Forces (IDF) have said they are looking into reports that Hamas has handed the body of hostage Shiri Bibas ...

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Alright folks, Kylie Kelce is back at it with another revelation about her relationship with former Philadelphia Eagles ...

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...